chiasma is a startup founded in 2010 based in France. Brouky records 1 investor associated with the company.
Chiasma is a biopharmaceutical company focused on developing and commercializing oral peptide therapies for the treatment of rare diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.